• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER CRIBRIFORM OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER CRIBRIFORM OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-MF-018
Device Problem Off-Label Use (1494)
Patient Problems Endocarditis (1834); Hemolysis (1886); Mitral Regurgitation (1964); Heart Failure (2206)
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
It was reported through a research article identifying amplatzer cribriform occluder that may be related to a sever hemolysis developed with pigmenturia, acute kidney injury, and ongoing blood transfusion required.Specific patient information is documented as unknown.Details are listed in the attached article, titled transcatheter repair of anterior mitral leaflet perforation.A transesophageal echocardiogram (tee) revealed torrential mitral regurgitation (mr) owing to 2 adjacent perforations in the a3 scallop of the anterior mitral valve leaflet (combined diameter of 10 mm), believed to be the sequelae of endocarditis.On an unknown date a 18mm amplatzer cribriform occluder was used for a mitral valve leaflet.On an unknown date the 18mm was snared and removed.A 20mm cardioform septal occluder (gore medical) was implanted.A few weeks later the patient was re-admitted for worsening heart failure and a tee was performed and confirmed worsening mr.The patient was referred to another center where a mitral valve replacement surgery was performed.
 
Manufacturer Narrative
Correction: please retract this report 2135147-2020-00074, the same issue was previously reported as 2135147-2020-00062.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER CRIBRIFORM OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9745930
MDR Text Key181824620
Report Number2135147-2020-00074
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/24/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-ASD-MF-018
Device Catalogue Number9-ASD-MF-018
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/13/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
-
-